Lastly, a recent paper shows IFITM3 is correlated with the inhibitory immune checkpoint receptors PD-L1, B7-H4, VISTA, IDO, and the tumor associated macrophage markers CD68, CD163, and CD206, which are associated with tumor immunosuppression (36). Here, IFITM3 is linked to neoplasm.